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Summary 
The neisserial  porins are the major protein components of the outer membrane of the patho- 
genic Neisseria  (N.  meningitidis  and N. gonorrhoeae). They have been shown to be able to en- 
hance the immune response to poorly immunogenic substances (e.g., polysaccharides, peptides, 
glycolipids, etc.). To explore the basis of their potent adjuvant activity, the effect of the neisser- 
ial porins on T-B cell interactions and T  cell costimulation was examined. Neisserial porins in- 
creased the surface expression of the costimulatory ligand B7-2 (CD86) but did not affect the 
expression of B7-1  (CD80).  In addition, incubation with the neisserial  porins increased the T 
lymphocyte costimulatory ability ofB lymphocytes, which was inhibited by anti-B7-2 but not 
anti-B7-1 monoclonal antibodies. Upregulation of B7-2 on the surface ofB lymphocytes may 
be the mechanism behind the immunopotentiating activity of neisserial porins. 
p rotein IA (PIA) and protein IB (PIB) of Neisseria gonor- 
rhoeae and  class  1,  2,  or 3  proteins  of N.  meningitidis 
(C1, C2, and C3 respectively) are the most abundant neis- 
serial outer membrane proteins (1). These proteins function 
as porins  (2--4), share significant homology (5-9), and are 
members  of the  gram-negative  porin  superfamily  (10). 
Neisserial outer membrane vesicle vaccines and purified neis- 
serial porin vaccine candidates induce immune responses in 
humans and animals without the addition of exogenous ad- 
juvants (11-14). Neisserial porin preparations augment the 
humoral  immune  response  to  poorly immunogenic  sub- 
stances, for example, peptides, and induce a T  cell-depen- 
dent immune response for normally T cell-independent anti- 
gens, for example, polysaccharides (15-18). Meningococcal 
OMV, mainly consisting of the class 2 protein, are used as 
carriers to boost the immune response towards the Haemo- 
philus  influenzae polysaccharide capsule  in  the  recently li- 
censed H.  influenzae type b vaccine (15).  The inclusion of 
purified PIA, PIB, C1, or C3 proteins in noncovalent com- 
plexes  containing  group  C  meningococcal capsular  poly- 
saccharides (CPS) greatly improves the antibody response in 
immunized mice to the polysaccharide compared with the 
1Abbreviations used in this paper: CPS, group C meningococcal  capsular 
polysaccharide; ICAM-1, intraceUular adhesion molecule-I; PIA, PIB, 
protein IA, IB, respectively;  Th, T-helper. 
Part of  this work was presented  at the Interscience  Conference  on Antimi- 
crobial Agents and Chemotherapy,  Sept. 17-20, 1995, San Francisco,  CA. 
anti-CPS  response  in  mice  immunized  with  CPS  alone 
(17).  Neisserial porins are used as adjuvants in anti-mela- 
noma cancer vaccines to augment the immune response to 
GM2 and GD3, two gangliosides present at much higher lev- 
els on malignant melanoma cells compared with normal hu- 
man melanocytes (18). 
We postulated that the porins' adjuvant ability could be 
related to their effect on interactions between T and B lym- 
phocytes, thereby increasing T  cell involvement in the im- 
mune response. In the current model ofT lymphocyte stim- 
ulation,  two  sets  of signals  between the  APC  and  the  T 
lymphocyte are required (19, 20). The first signal  (signal  1) 
is delivered via the interaction of  the MHC on APC (e.g., B 
lymphocytes, dendritic cells, macrophages, etc.) and the TCR 
on T lymphocytes. This interaction confers antigenic spec- 
ificity. The second or costimulatory signal  (signal 2) is de- 
livered by the binding of two sets of counterreceptors dur- 
ing the interaction between the B and T  lymphocytes. 
The most significant B lymphocyte counterreceptors are 
B7-1  (BB1, CD80)  (21,  22) and the more recently discov- 
ered B7-2 (CD86) (23-27). The costimulatory ligands of  the 
B7 family are expressed on professional APC:  activated B 
lymphocytes, macrophages and dendritic cells (21,  22, 28- 
32).  The B7 family of ligands  bind to two T  lymphocyte 
counterreceptors, CD28 and CTLA-4 (19,  20).  It appears 
that B7-2 has  a greater role in stimulating T  lymphocytes 
than B7-1  (19,  20). The expression of B7-2 occurs earlier 
than the expression of B7-1, and there is more B7-2 present 
on the surface of activated B lymphocytes than B7-1  (19, 
20,  33,  34).  Most  importantly,  the  upregulation  of B7-1 
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of the  ability of B  lymphocytes to  costimulate T  lympho- 
cytes (19, 20). The effect of neisserial porins on B  lympho- 
cyte stimulation and costimulatory ligand expression (B7-1 
and B7-2) was examined as a possible mechanism by which 
porins enhance the immune response to other antigens. 
Materials and Methods 
Animal Strains.  Lymphocytes were isolated from LPS-resistant 
mice, strain C3H/HeJ  (35),  or their LPS-responsive related strain 
C3H/HeOuJ.  7-8-wk-old mice were  used in the  experiments. 
Both strains were obtained from The Jackson Laboratory (Bar Har- 
bor, ME). LPS-resistant mice were used in all experiments in order 
to prevent confounding results secondary to contaminating LPS. 
Antibodies.  The following mAbs were  used in the  B  and T 
lymphocyte isolations: anti-Thyl.2 (mouse IgM,  TIB 99, clone 
HO.13.4), anti-class II MHC, IA  k (mouse IgG2b, TIB 93, clone 
10.2.16) and anti-CD8 (rat IgG 2b, TIB 211, clone 3.155). They 
were all obtained from myeloma cell lines purchased from Amer- 
ican Type  Culture  Collection (Rockville ME)).  The  following 
rnAbs were  used in flow cytometry analysis:  anti-murine B7-1- 
FITC (24)  [hamster F(ab)2; clone 16-10A1], anti-murine B7-2- 
FITC  (Rat  lgG2a;  PharMingen,  San  Diego,  CA;  clone GL-1) 
(25),  anti-class  II  MHC-IA~-PE  (mouse  lgG2a;  PharMingen; 
clone 11-5.2), anti-murine CD23-FITC (rat lgG2a; PharMingen; 
clone B3B4), anti-murine heat-stable antigen-FITC (CD24)  (rat 
lgG2b; PharMingen; clone MI/69), anti-murine intracellular ad- 
hesion moleoale (ICAM)-I-FITC (CD54) (hamster IgG; PharMin- 
gen; clone 3E2). A mixture ofnonspecific murine IgG mAbs was 
added to each reaction mixture to block nonspecific Fc receptor 
binding (Becton  Dickinson lmmunocytochemistry System,  San 
Jose,  CA).  Rat  IgG2a-FITC  (PharMingen)  or  hamster  IgG- 
FITC (PharMingen; clone UC8-4B3)  were  used as controls to 
check  for  nonspecific binding.  Anti-CD3  mAb  (hamster  lgG/ 
PharMingen; clone  145-2Cll)  was  used  to  cross-link CD3  on 
purified T  lymphocytes in the  costimulation a~ay  (see  below). 
Anti-murine  B7-1  [hamster  F(ab)z;  obtained  from  Dr.  Hans 
Reiser)  or  anti-murine B7-2  (PharMingen;  clone  GL-1)  were 
used in the costimulation experiments to investigate their ability 
to inhibit T  lymphocyte cosdmulation. 
Bacterial Porins and Products.  Nei~erial porins were purified by 
detergent  extraction  and  column chromatography  as  described 
previously (36-38). Briefly, gonococci or meningococci were re- 
suspended in l  M  sodium acetate, pH 4.0, and then a solution of 
0.5  M  CaCI  2,  5%  Zwittergent was  added,  and the  supernatant 
was obtained by centrifugation. The protein was precipitated by 
the addition of ethanol to a concentration of 80% and then resus- 
pended in a 50-raM Tris, pH 8.0, 5%-Zwittergent buffer, h  was 
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Figure 1.  Neisserial  porins induce B lym- 
phocytes to express B7-2  molecules. Puri- 
fied  murine B  lymphocytes  isolated form 
C3H/HeJ mice were incubated  with puri- 
fied neisserial porins  or medium alone  for 
48  h.  The  treated  B  lymphocytes  were 
stained with nonspecific rat  IgG--FITC  or 
PE  (curve closest to  vertical scale), anti-B7-1- 
FITC,  anti-B7-2-FITC,  or  anti-IA~'--PE 
(MHC class ll) (the second curve in each panel). 
(A) Histograms of fluorescence intensity ob- 
tained for each set of B lymphocytes incu- 
bated with media alone or each of the neis- 
serial porins at a concentration of 10 p,g/ml, 
when analyzed by flow cytometry  (10,000 
cells were  evaluated per sample). The data 
displayed are from a representative experi- 
ment. (B) Geometric mean cellular fluores- 
cence intensity  obtained  for each set of B 
lymphocytes  incubated  with  decreasing 
concentrations  of PIB  (10, 5, 2,  1, 0.5, or 
0.1  Ixg/ml) upon labeling with anti-B7-2- 
FITC. The data displayed are from a rep- 
resentative  experiment.  The  experiments 
shown in A  and B were  performed  four 
times, essentially  with identical results. 
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molecular sieve column. PIA (34 kD) and PIB (35 kD) were pu- 
rified from gonococcal strains lacking protein III (11, 38), and C1 
(40 kD) and C3 (34 kD) proteins were purified from meningo- 
coccal strains lacking class 3  and 4  or class  1 and 4 proteins, re- 
spectively (39,  40).  The  porins  were  isolated from  the  mutant 
neisserial strains  to  avoid  contamination  of the  purified porin 
preparations with other major outer membrane proteins. Negligi- 
ble contamination by other proteins and LPS was demonstrated 
by gel electrophoresis (data not shown). The porins used for in- 
cubation  with  the  B  cells were formed  into proteosomes  (11), 
pure  protein micelles, to  eliminate all detergents that  could be 
toxic  to  the  lymphocytes.  Neisserial LPS  (3.6  kD)  was  kindly 
provided by Dr.  Michael Apicella (University of Iowa Medical 
Center, Iowa City IA) (41). 
Lymphocyte Isolation.  Single-cell  suspensions  of spleens  and 
mesenteric  lymph  nodes  were  depleted  of red  blood  cells by 
treatment with PBS/NH4CI  (42).  B lymphocytes were obtained 
by negative selection through complement lysis using anti-T cell 
mAbs (anti-Thy 1.2,  anti-CD4, and anti-CD8) with guinea-pig 
complement (Sigma Chemical Co., St.  Louis, MO) followed by 
removal of adherent cells on  a  G10  sephadex column  (42).  Th 
cells  (CD4*)  were  obtained by enrichment  over a  nylon wool 
column  and  subsequent  complement  lysis  using  anti-class  II 
MHC  (anti-IA  k) and  anti-CD8  mAbs with guinea pig comple- 
ment (42, 43). Medium used was ILPMI (pH 7.4) with 10~  heat- 
inactivated  FCS  (HyClone  Laboratories,  Inc.,  Logan  UT),  50 
I.tM 2-ME, 2 mM glutamine, 100 U/rnl penicillin, and  100 ~g/ 
ml streptomycin .0~ 10). 
B Lymphocyte Incubation with Neisserial Porins.  B  lymphocytes 
(5  X  106/ml)  were  incubated with  neisserial porins,  PIA,  PIB, 
C1, or C3 protein, formed into proteosomes, for 2 d in humidi- 
fied  5%  CO  2  at  37~  Incubation  with  dextran  (20  wg/ml) 
(Sigma Chemical Co,}  was used as a positive control as this mix- 
ture has previously been shown to induce B7-1  or B7-2 expres- 
sion on  B  lymphocytes (22,  44,  45).  Incubation with  gl0  cell 
culture media alone was  used as a negative control. The B  cells 
were harvested and separated from dead cells and debris by den- 
sity gradient centrifugation (Ficoll-Hypaque) (42, 43).  The cells 
were viable as tested by trypan blue exclusion (43). 
B Lymphocyte Proliferation F_xper/ments.  B lymphocytes from LPS- 
nonresponsive strain  C3H/HeJ  or .LPS-responsive strain  C3H/ 
HeOuJ, or purified T fymphocytes from LPS-nonresponsive strain 
C3H/HeJ  (see below) were incubated as above with PIB or puri- 
fied neisserial LPS at a concentration of 10 v,g/ml (3 nM .LPS or 
0.3 nM PIB) for 48 h. Control incubations contained only media. 
The B or T  lymphocytes, 5  ￿  106/ml,  100  wl/well in triplicate, 
were incubated in humidified 5% CO  2 at 37~  .w~th PlB, LPS, or 
media. After 2 d the ceils were pulsed with 1 p,  Ci, [3H]thyrmdlne 
per well. After an additional 18-h incubation, the wells were har- 
vested onto filter paper discs,  and the [3H]thymidine incorpora- 
tion, as a measure of PlB- or LPS-induced proliferation, was mea- 
sured on a 13 scintillation counter. 
Flow Cytometry Evaluation.  The  expression of B  lymphocyte 
surface antigens was studied by flow cytometric analysis of single- 
cell suspensions using a  FACScan  |  (Becton Dickinson &  Co.). 
(46).  Data were  analyzed using LYSYS  TM  or CELL  QUEST  TM 
FACS  |  analysis software (Becton Dickinson, & Co.). The B lym- 
phocytes, previously incubated with  neisserial porins,  were  ali- 
quotted and incubated with the anti-B cell surface ligand fluoro- 
chrome conjugate mAb mentioned above, per standard protocols 
(46).  Specificity of the  anti-BT-1-FITC  and  anti-B7-2-FITC 
binding was evaluated by the addition of unlabeled anti-B7-1 or 
anti-B7-2 mAb to reaction mixtures, which  completely ablated 
any  signal of their respective fluorochrome  conjugate  antibody 
conjugates (data not shown). Nonspecific binding via the Fc por- 
tion of the mAbs was  blocked by the addition of a  mixture of 
mouse  mAbs  (lgGl,  lgG2a,  IgG2b)  to  each  reaction  mixture. 
FITC-labeled rat or hamster IgG was used as isotype controls in 
certain reaction mixtures to determine the nonspecific binding of 
these species of antibodies to B lymphocytes. 
Cell Cycle Evaluation.  To evaluate the percentage of B  lym- 
phocytes in the various stages  of the cell cycle (G1,  S, G2,  and 
M),  the following experiments were performed. B  lymphocytes 
were  incubated in  medium containing PIB  or neisserial LPS  at 
various concentrations for 2 d as described above. Freshly isolated 
B  lymphocytes  and  B  lymphocytes  incubated  in  plain  media 
(R10) were included in the evaluations as controls. All cells were 
fixed and permeabilized by washing with  ice-cold 70~  ethanol. 
DNA was stained with propidium iodine (50 v,g/ml) in PBS, 2% 
FCS for 1 h. The cells and DNA content were analyzed by flow 
cytometric methods as previously described (46). As the ploidy of 
the DNA increases, indicating cells entering the synthetic and mi- 
totic  phases  of the  cell  cycle,  each  cell  incorporates  greater 
amounts ofpropidium, whose fluorescence can be measured and 
quantitated. 
T Lymphocyte Costimulation.  B lymphocytes, activated by por- 
ins,  were  incubated with  CD3-cross-linked CD4 +  T  lympho- 
1153  Wetzler et al. Figure 2.  Neisserial  porins induce B lymphocytes to proliferate. (A) Purified B lymphocytes from C3H/HeJ mice were incubated, at a concentration 
of 5 ￿  106/ml, with purified neisserial PIB (10, 5, 1, or 0.1 Ixg/ml; 0.3, 0.15, 0.03, or 0.003 I~M,  respectively)  or medium alone for 48 h and then pulsed 
with [3H]thymidine. [3H]Thymidine incorporation (cpm, on the y-axis)  was measured as an indicator of lymphocyte prohferation. The data displayed  are 
from one typical experiment; experiments were performed three times. (B) The DNA content of freshly  isolated B lymphocytes or B lymphocytes incu- 
bated with medium alone or PIB (10 I.Lg/ml,  0.3 ~M) was determined by propidium iodine (PI) staining and measuring the PI retention by the DNA us- 
ing flow cytometry. The B lymphocytes were isolated from C3H/HeJ mice. As the amount of DNA per cell increases, the greater each cell incorporates 
PI after permeabilization by ice-cold ethanol. The greater the DNA content, the more cells are in the cell cycle. The area of  the plot to the far left shows 
cells in the first gap phase (G1), the area to the far fight shows cells in the second gap phase (G2) or mitotic phase (M), and the area in between shows cells 
in the synthesis phase (S). B cells from LPS-responsive murine strain C3H/HeOuJ all had similar profiles when incubated either PIB or LPS (data not 
shown). The experiments were performed three times, with essentially  identical results. 
cytes to measure the B cells' ability to costimulate the T  cells (22, 
25, 44, 45, 47, 48). The CD3  antigens on T  lymphocytes were 
cross-linked by incubation with anti-CD3 mAb, 1 ~g/ml, for 1 h 
before the addition of the B lymphocytes. B lymphocytes, previ- 
ously incubated with the neisserial porins or media alone, were 
fixed with mitomycin C, 50 I~g/ml, for 30 min at room temper- 
ature. Various numbers of these fixed B lymphocytes (103 to 2  ￿ 
105) were added to 96-well tissue culture plates containing CD3- 
cross-hnked CD4 + T  lymphocytes, 2  ￿  10S/well. The mixtures 
of B and T  cells were incubated in humidified 5% CO  2 at 37~ 
and  after 2  d  they were  pulsed with  1  IxCi [3H]thymidine per 
well. 18 h later, the cells from each well were harvested onto fil- 
ter paper discs,  and  [3H]thymidine incorporation was  measured 
on a gamma counter. Anti-B7-1 or anti-B7-2 mAbs or appropri- 
ate isotype controls (hamster IgG or rat IgG 2a)  were added to 
wells containing porin-incubated B lymphocytes and CD3-cross- 
linked T  lymphocytes to determine the specificity of the B lym- 
phocyte costimulatory activity. 
Results 
To  examine if neisserial porins affect the surface expres- 
sion of B7-1  and B7-2  on B  lymphocytes and increase B 
lymphocyte  costimulatory  ability, murine  B  lymphocytes 
were  purified  from  spleens  of LPS-nonresponsive  mice, 
strain C3H/HeJ  (35, 49), and incubated with neisserial por- 
ins formed into proteosomes (11). The porin-treated B lym- 
phocytes were labeled with anti-B7-1, anti-B7-2, or anti- 
IA  k (class II MHC)  fluorochrome conjugates, and the level 
of surface  expression was  determined by flow  cytometric 
analysis.  48  h  after  incubation  with  the  neisserial  porins 
PIA, PIB, C1, or C3, B  lymphocytes expressed more B7-2 
on their surface compared with B  cells incubated with me- 
dia alone (Fig. 1 A). The upregulation of surface expression 
of B7-2  occurred in a  dose-dependent manner  (Fig.  1 B). 
Importantly, the  effects of the  neisserial porins were  very 
specific. The  porins also induced the  expression of MHC 
class II and, to a small degree, ICAM-1  (CD54)  molecules. 
In contrast, neisserial porins did not induce the  expression 
of B7-1,  heat-stable antigen  (CD24),  or CD23  at all con- 
centrations tested (0.1-10.0  p~g/ml) (data not shown). 
The ability of the porins to induce B  lymphocyte prolif- 
eration was measured by [3H]thymidine incorporation ex- 
periments. PIB was able to induce proliferation of purified 
B  lymphocytes from  strain  C3H/HeJ  in  a  concentration- 
dependent manner  (10.0-0.1  ixg/ml, 0.3-0.003  ~M)  (Fig. 
2 A). PIB could not induce T  cell proliferation (Fig. 3  A). 
In addition, PIB  was  able to  induce  progression of the  B 
lymphocytes into the cell cycle. This was performed by an- 
alyzing the DNA content of freshly isolated B  lymphocytes 
and  B  lymphocytes  incubated  in  media  or  with  PIB  (10 
~g/ml, 0.3 nM) and measured by propidium iodine uptake 
using flow  cytometric methods  (46).  PIB  was  able to  in- 
crease the percentage of B  cells into the synthesis phase  (S) 
and the second gap and mitotic phase  (G2/M)  by two- to 
fourfold over freshly isolated B  cells or B  cells incubated 
with media alone. 
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contamination  of the  neisserial porin preparations by LPS 
was responsible for B lymphocyte proliferation and induced 
B7-2  expression.  Purified B  lymphocytes from  LPS-non- 
responsive murine strain C3H/HeJ  or from equivalent but 
LPS-responsive  murine  strain  C3H/HeOuJ  were  incu- 
bated with  media,  PIB  (10  I~g/ml, 0.3  nM),  or neisserial 
LPS (10 ~g/ml. 3.0 nM) separately. PIB was able to induce 
proliferation of C3H/HeJ  B  cells, whereas  LPS  or media 
alone could not (Fig. 3 A). Both PIB and LPS were able to 
induce  proliferation  of  B  lymphocytes  from  the  LPS- 
responsive strain C3H/HeOuJ  (Fig. 3 A). Moreover, incu- 
bation  of  B  lymphocytes  from  both  strains  with  PIB 
induced  a  greater number  of cells to  enter  the  cell cycle 
compared with  media-incubated B  cells. In contrast,  LPS 
incubation  of  B  lymphocytes  only  from  strain  C3H/ 
HeOuJ  (and not strain C3H/HeJ)  induced a  greater num- 
ber of cells to  enter the  cell cycle compared with media- 
incubated B  cells (data not shown).  Finally, the expression 
of B7-2  on  B  lymphocytes,  upon  incubation  with  PIB, 
LPS, or media alone, was analyzed (Fig. 3  B). PIB was able 
to increase B7-2  expression using B  lymphocytes from ei- 
ther  C3H/HeJ  or C3H/HeOuJ  mice.  However,  LPS was 
only able to increase B7-2 surface expression on B lympho- 
cytes  from  C3H/HeOuJ  mice.  Control  incubation  with 
media alone did not increase B7-2 surface expression on ei- 
ther set ofB  lymphocytes (Fig. 3  B). B7-1  surface expres- 
sion did not increase on any set ofB lymphocytes (data not 
shown). Importantly, LPS was used at a  10-fold higher mo- 
lar concentration than PIB in these experiments. Taken to- 
gether,  these data strongly suggest that the induction of B 
cell proliferation and B7-2  expression on  the surface of B 
lymphocytes by the  neisserial porins is due  to  the protein 
itself, and not to LPS contamination. 
Figure 3.  The B lymphocyte stimulatory activity of neisserial  porins is not due to contamination with LPS. (A) Purified B lymphocytes from either 
LPS-nonresponsive murine strain C3H/HeJ or from the LPS-responsive  strain C3H/HeJ were incubated, at a concentration of 5 ￿  106/ml,  with puri- 
fied neisserial  LPS (10 ~.g/ml, 3 ~M), PIB (10 ~,g/ml, 0.3 p.M) or medium alone for 48 h and then pulsed with [3H]thymidine.  T lymphocytes were ob- 
tained from strain C3H/HeJ and were used at a concentration of 5 ￿  106/ml. [3H]Thymidine incorporation (cpm,  on the y-axis) was measured as an in- 
dicator of PIB- or LPS-induced B lymphocyte proliferation. The data displayed are from one typical experiment; experiments were performed three 
times. (B) Purified B lymphocytes from either the LPS-nonresponsive murine strain C3H/HeJ or the LPS-responsive  strain C3H/HeOuJ at a concentra- 
tion of 5 X 106/ml were incubated with purified neisserial  LPS (10 I.Lg/ml,  3 ~.M), PIB (10 p,g/ml, 0.3 ~M), or medium alone for 48 h. The surface ex- 
pression of  B7-2 (CD86) was then determined by labeling with anti-B7-2-FITC conjugate and subsequent analysis  by flow cytometry. 10,000 cells were 
analyzed  per sample. Media incubated B lymphocytes (dashed  line), LPS-incubated B lymphocytes (thin solid line), PIB-incubated B lymphocytes (thick solid 
line). The data displayed  are from one typical experiment; experiments were performed three times. 
1155  Wetzler et al. Next, the ability of B lymphocytes incubated with neis- 
serial  porins to  costimulate autologous CD4  + T  lympho- 
cytes was measured. CD4 + T  lymphocytes were incubated 
with anti-CD3 mAb to cross-link the TCR and mimic sig- 
nal 1 in the model ofT cell costimulation (50-52). Increas- 
ing numbers of mitomycin C-treated B .lymphocytes pre- 
incuba~d  with P IA,  PIB,  or media were incubated with 
CD3-cross-linked  T  lymphocytes.  B  lymphocytes  incu- 
bated  with  the  porins were able to stimulate  T  lympho- 
cytes, whereas B lymphocytes incubated with media alone 
were not able to stimulate the T  lymphocytes (Fig.  4 A). 
Importantly, the ability of B lymphocytes to costimulate T 
lymphocytes also increased with the concentration of PIB 
with which the B lymphocytes were incubated (Fig.  4  B). 
The increase in  costimulatory activity correlates with  the 
upregulation  of B7-2  expression noted above  (Fig.  1  B). 
This indicates that the ability of the neisserial  porins to in- 
duce B cell costimulatory activity is related to the amount of 
porin the B lymphocyte encounters. T  lymphocyte stimu- 
lation by the B cells incubated with PIA or PIB was inhib- 
ited by the addition of anti-B7-2 mAb to the reaction mix- 
tures (>80%) and only minimally inhibited by the addition 
of anti-B7-1 to the reaction mixtures (<20%) (Fig. 5). The 
addition of both mAbs totally inhibited the costimulatory 
ability of the B  lymphocytes. It is not surprising that  the 
anti-B7-1 mAb could inhibit a small amount of the B lym- 
phocyte  costimulatory  ability  since  B7-1  expression  in- 
creases  on all incubated B lymphocytes (including media- 
incubated B lymphocytes) compared with freshly isolated B 
lymphocytes (see Fig.  1). The addition of control nonspe- 
cific rat IgG mAb did not affect the costimulation ofT lym- 
phocytes by the B lymphocytes incubated with PIA or PIB. 
Discussion 
There is evidence presented by various investigators that 
microbial products can stimulate B lymphocytes. LPS, mi- 
togenic iaafluenza virus, and an antigen that mimics viral in- 
fection (polyinosinic-polycytidylic  acid), have all been shown 
to stimulate B  lymphocytes, which in  turn  costimulate T 
lymphocytes (53).  Purified Salmonella typhi porins  (free of 
LPS) have been demonstrated to be potent B  cell stimula- 
tors, but have minimal effect on T  lymphocytes (54, 55). In 
addition,  meningococcal  outer  membrane  preparations, 
mainly consisting of the meningococcal porins, act as B cell 
mitogens and do not stimulate T lymphocytes (56-58). The 
data presented in this study are consistent with these previ- 
ous findings. Neisserial porins are potent B cell stimulators 
and have minimal, if  any, effects on T lymphocytes, includ- 
ing T  lymphocytes that have been activated by TCR cross- 
linking by anti-CD3 mAb (data not shown). More specifi- 
cally, the neisserial  porins can stimulate B lymphocytes and 
induce upregulation of the  costimulatory ligand  B7-2  on 
the surface of B lymphocytes. B lymphocytes treated with 
neisserial  porins can stimulate T  lymphocytes whose TCRs 
have  been  cross-linked  by  anti-CD3  mAbs.  The  CD3 
cross-linking mimics engagement of TCR by class II MHC 
whose  peptide-binding  clefts  are  occupied  by  antigen- 
derived oligopeptides (T cell epitope). 
LPS, including neisserial  LPS, is an extremely effective B 
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Figure  4.  Neisserial  porins  in- 
duce B  lymphocytes to  express co- 
stimulatory  activity.  (A)  Cultures 
were  constructed  with  anti-CD3- 
activated CD4  §  T  lymphocytes and 
mitomycin C-treated B  cells prein- 
-cubated with PIA,  PIB,  or medium 
alone.  The  x  axis  represents  the 
number of B  lymphocytes added to 
each reaction nuxture containing 2  ￿ 
10  s T  lymphocytes per well. Stimu- 
lation  of T  lymphocytes by B  lym- 
phocytes preincubated with neisserial 
porins  was  quantitated  by  [3Hlthy- 
midine  incorporation  (y  axis).  All 
cultures  were  constructed  in  tripli- 
cate. (/3) T  lymphocyte costimulation 
experiments were performed using B 
lympbocytes incubated with increas- 
ing concentrations of PIB  as  noted 
in  the figure.  After 2  d  of incuba- 
tion, the B  lymphocytes were fixed 
with  miromycin  c  and  used  in  T 
lymphocyte costimulation assays. The 
number  of  T  lymphocytes  and  B 
lymphocytes used was 2  ￿  10S/well. 
The amount of T  lymphocyte stim- 
ulation induced by the porin-treated 
B  lymphocytes  was  measured  by 
[3H]thymidine  uptake  as  in  Fig.  3 
and is displayed on the y axis. l~igure 5.  The costimulatory activity ofporin-stimu- 
lated B  lymphocytes is  inhibited  by anti-B7-2  anti- 
body. T  lymphocyte costimulation experiments were 
performed as described in Materials and Methods and 
the  legend to  Fig. 4  using B lymphoeytes incubated 
with PIA or PIB, with additional reaction nuxtures that 
contained the following mAbs: anti-B7-1  (clone ~IG10, 
rat IgG2a), anti-B7-2-(clone  GI-1, rat lgG2a), or non- 
specific rat igG2a mAb, 10 I~g/rnl. All data poir~ were 
performed in triphcate. Data are reported as the aver- 
age [3H]thymidine uptake (cpm) of wells containing no 
antibody, rat IgG control antibody, anti-B7-1, or anti- 
B7-2 mAh, minus the average [3H]thyrmdine uptake 
(cpm)  in  wells only  containing  anti-CD3--aemvated 
CD4 + T  lymphocytes (n  =  10). The  number  of T 
lymphocytes used was  2  X  10S/well each, and  the 
number  of B lymphocytes per well is labeled on the 
),-axis. This is the average of three experiments. 
cell mitogen and can increase expression of BT-1  and B7-2 
on  B  lymphocytes,  inducing  potent  costimulatory  activity 
(28,  53).  For  a  number  of reasons,  porin-inducod  B  cell 
prohferation  and increased B7-2  expression  are most likely 
not due to LPS contamination  of the neisserial porin prep- 
arations.  B  lymphocytes were purified from phenotypicaUy 
LPS-nonresponsive  mice  (strain  C3H/HeJ).  LPS  at  equi- 
molar or greater concentrations  compared with  PIB could 
not  induce  B7-2  expression  (Fig.  3  B)  and  could  not  in- 
duce B  cell prohferation  as measured by [3H]thyxnidine  in- 
corporation  using  lymphocytes  from  LPS-nonresponsive 
mice (Fig. 3 A). The LPS used was a potent stimulator of B 
lymphocytes from the  related  LPS-responsive strain  C3H/ 
HeOuJ.  Finally,  the  purified  porin  preparations  described 
and  used  in  these  studies  had  minimal  contamination  by 
LPS as demonstrated by gel electrophoresis and silver stain- 
ing, and by hmulus  lysate assays (<0.01%)  (11,  40, 59). 
It  has  been  previously  shown  that  the  neisserial  porins 
are immunogenic without additional adjuvants and that they 
are potent stimulators of the immune response to otherwise 
poorly immunogenic substances  (11-14,  17,  18).  It is likely 
that  the  ability  of the  porins  to  augment  the  immune  re- 
sponse  to  other  antigens  is related  to  their  induction  of B 
lymphocyte  costimulatory  ability  and  subsequent  T  lym- 
phocyte costimulation.  In individuals  immunized with vac- 
cines  containing  neisserial  porins  complexed  with  specific 
potentially protective antigens,  the antigen of interest would 
at first bind  to surface immunoglobulin  of antigen-specific 
B  lymphocytes.  This  allows  the  porin  present  in  the  vac- 
cine complex to come in dose proximity to the B lympho- 
cyte,  stimulate  the B  lymphocyte,  and  increase surface ex- 
pression  of B7-2.  The  B  lymphocytes,  with  increased  T 
lymphocyte  costimulatory  ability,  then  stimulate  T  lym- 
phocytes.  Once  activated  in  this  manner,  T  lymphocytes 
release  various  cytokines,  including  IL-2 and  IL-4,  which 
positively affect anta~body production.  IL-2 and IL-4 induce 
B  lymphocytes to become antibody-secreting  cells,  induce 
isotype switching from lgM to lgG, and allow T  cell mem- 
ory to occur, which  is especially important if the antigen of 
interest is T  cell independent,  e.g., polysaccharide  (60--63). 
Expression  of B7-2  has been demonstrated  on cell  types 
other  than  B  lymphocytes,  including  dendritic  cells  and 
macrophages (28, 32).  It remains to be determined whether 
neisserial  porins  have  any  effect  on  the  activity  of these 
APC.  It is unclear by which  mechanisms the porins stimu- 
late B  lymphocytes.  Possibilities include  direct intercalation 
of the porins into the membrane of the B  lymphocyte, An- 
other possible mechanism is that the porins bind and stimu- 
late B  lymphocytes via specific unrecognized  surface recep- 
tors.  Work  is in  progress  exploring  both  such  hypotheses. 
The  better  the  understanding  of the  mechanism  of adju- 
vants,  the better we will be able to use their immune-aug- 
menting activity in future vaccines. 
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